ALGL_PSESY
ID ALGL_PSESY Reviewed; 378 AA.
AC Q9L7P2;
DT 27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-2000, sequence version 1.
DT 03-AUG-2022, entry version 85.
DE RecName: Full=Alginate lyase {ECO:0000255|HAMAP-Rule:MF_00557, ECO:0000303|PubMed:11029455};
DE EC=4.2.2.3 {ECO:0000255|HAMAP-Rule:MF_00557, ECO:0000269|PubMed:11029455};
DE AltName: Full=Poly(beta-D-mannuronate) lyase {ECO:0000255|HAMAP-Rule:MF_00557, ECO:0000305|PubMed:11029455};
DE Flags: Precursor;
GN Name=algL {ECO:0000255|HAMAP-Rule:MF_00557, ECO:0000303|PubMed:11029455};
OS Pseudomonas syringae pv. syringae.
OC Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC Pseudomonadaceae; Pseudomonas; Pseudomonas syringae.
OX NCBI_TaxID=321;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 29-38, FUNCTION,
RP CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, ACTIVITY REGULATION,
RP BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP HIS-204 AND TRP-207.
RC STRAIN=FF5;
RX PubMed=11029455; DOI=10.1128/jb.182.21.6268-6271.2000;
RA Preston L.A., Wong T.Y., Bender C.L., Schiller N.L.;
RT "Characterization of alginate lyase from Pseudomonas syringae pv.
RT syringae.";
RL J. Bacteriol. 182:6268-6271(2000).
CC -!- FUNCTION: Catalyzes the depolymerization of alginate by cleaving the
CC beta-1,4 glycosidic bond between two adjacent sugar residues via a
CC beta-elimination mechanism. Degrades deacetylated polymannuronate
CC (polyM) alginate from P.aeruginosa more efficiently than non-
CC deacetylated polyM and alginate from M.pyrifera. AlgL from P.syringae
CC degrades also its own alginate, which may indicate a role in cleaving
CC preformed alginate and/or in determining the length of the alginate
CC polymer (PubMed:11029455). May serve to degrade mislocalized alginate
CC that is trapped in the periplasmic space (By similarity).
CC {ECO:0000255|HAMAP-Rule:MF_00557, ECO:0000269|PubMed:11029455}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=Eliminative cleavage of alginate to give oligosaccharides with
CC 4-deoxy-alpha-L-erythro-hex-4-enuronosyl groups at their non-reducing
CC ends and beta-D-mannuronate at their reducing end.; EC=4.2.2.3;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_00557,
CC ECO:0000269|PubMed:11029455};
CC -!- ACTIVITY REGULATION: The monovalent cation sodium enhances activity but
CC is not absolutely required. {ECO:0000269|PubMed:11029455}.
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC pH dependence:
CC Optimum pH is 7.0. {ECO:0000269|PubMed:11029455};
CC Temperature dependence:
CC Optimum temperature is 42 degrees Celsius.
CC {ECO:0000269|PubMed:11029455};
CC -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000269|PubMed:11029455}.
CC -!- SIMILARITY: Belongs to the polysaccharide lyase 5 family.
CC {ECO:0000255|HAMAP-Rule:MF_00557}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF222020; AAF32371.1; -; Genomic_DNA.
DR RefSeq; WP_003365409.1; NZ_MLEV01000001.1.
DR AlphaFoldDB; Q9L7P2; -.
DR SMR; Q9L7P2; -.
DR CAZy; PL5; Polysaccharide Lyase Family 5.
DR PATRIC; fig|321.63.peg.1597; -.
DR BRENDA; 4.2.2.3; 5193.
DR GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR GO; GO:0045135; F:poly(beta-D-mannuronate) lyase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0042122; P:alginic acid catabolic process; IEA:UniProtKB-UniRule.
DR CDD; cd00244; AlgLyase; 1.
DR Gene3D; 1.50.10.100; -; 1.
DR HAMAP; MF_00557; Alginate_lyase; 1.
DR InterPro; IPR022859; Alginate_lyase.
DR InterPro; IPR008397; Alginate_lyase_dom.
DR InterPro; IPR008929; Chondroitin_lyas.
DR Pfam; PF05426; Alginate_lyase; 1.
DR SUPFAM; SSF48230; SSF48230; 1.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Lyase; Periplasm; Signal.
FT SIGNAL 1..28
FT /evidence="ECO:0000269|PubMed:11029455"
FT CHAIN 29..378
FT /note="Alginate lyase"
FT /id="PRO_0000024922"
FT BINDING 67..68
FT /ligand="substrate"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00557"
FT BINDING 140..141
FT /ligand="substrate"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00557"
FT BINDING 258
FT /ligand="substrate"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00557"
FT MUTAGEN 204
FT /note="H->A: Loss of activity."
FT /evidence="ECO:0000269|PubMed:11029455"
FT MUTAGEN 207
FT /note="W->A: Loss of activity."
FT /evidence="ECO:0000269|PubMed:11029455"
SQ SEQUENCE 378 AA; 42542 MW; 33E5894BC6404F14 CRC64;
MQTPKLIRPT LLSMAILSSM AWATGASAAL VPPKGYDAPI EKMKTGDHNF SCEAIPKPYT
DKLVFRSKYE GSDKARATLN AVSEEAFRDA TKDITTLERG VSKVVMQYMR DGRPEQLDCA
LNMMTTWAKA DALESREFNH TGKSMRKWAL GSMSSAYLRL KFSESHPLAN RQQDAKIIET
WFSKLADQVV SDWSNLPLEK INNHSYWAAW SVMATAVATN RQDLFDWAVK EYKVAANQVD
KDGFLPNEMK RRQRALSYHN YALPPLAMIA SFAQANGVDL RPENNGALKR LGDRVLAGVK
DPSIFAEHNG EKQDMTDLKK DPKFAWLEPY CSLYTCSPDV LEEKHEKQPF KTFRLGGDLT
KVYDPTHEKG DKGDNDGS